advances in testing: a personalized, ctdna assay for mrd detection and surveillance
Published 3 years ago • 3.6K plays • Length 18:43Download video MP4
Download video MP3
Similar videos
-
49:45
a ctdna assay for remote monitoring and risk stratification
-
2:19
introducing signatera, a personalized, tumor-informed test
-
49:25
incorporating a personalized, tumor-informed ctdna monitoring assay in clinical practice
-
35:05
a ctdna assay for remote monitoring and risk stratification of crc patients
-
3:44
angela's story with signatera
-
10:02
mrd detection rates with a personalized and a tumor-informed ctdna assay in patients with stage ...
-
8:45
jun gong, md | ctdna and mrd testing with the expanded access program
-
2:27
the signatera approach
-
2:48
is the cancer coming back? using signatera to detect molecular residual disease (mrd)
-
3:25
understand ctdna testing
-
1:05:21
ctdna and mrd testing | colorectal cancer care tools for surveillance
-
2:22
signatera for immunotherapy response monitoring
-
0:40
how does signatera for immunotherapy response monitoring work?
-
9:00
adham jurdi, md | ctdna and mrd testing with the expanded access program
-
5:34
farshid dayyani, md | ctdna and mrd testing with the expanded access program
-
9:35
methods for ctdna detection and analysis
-
46:53
ctdna and mrd: who, when, and then what? | 2022 evolution conference
-
6:08
natera: personalized genetic testing and diagnostics
-
44:59
deep dive into the utility of personalized mrd monitoring -- 2020 asco recap